Crossmark

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)

Crossref DOI link: https://doi.org/10.1038/s41416-018-0337-x

Published Online: 2018-11-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toss, Michael S.

Miligy, Islam M.

Gorringe, Kylie L.

AlKawaz, Abdulbaqi

Khout, Hazem

Ellis, Ian O.

Green, Andrew R.

Rakha, Emad A.
License Information

Text and Data Mining valid from 2018-11-09
More Information

Article History

Received: 17 August 2018

Revised: 9 October 2018

Accepted: 25 October 2018

First Online: 9 November 2018

Competing interests

: The authors declare no competing interests.

: The datasets generated during and/or analysed during the current study are available from the corresponding authors on reasonable request.

: This research was supported and funded by the Egyptian Ministry of Higher Education and Scientific Research.

: This work obtained ethics approval by the North West – Greater Manchester Central Research Ethics Committee under the title; Nottingham Health Science Biobank (NHSB), reference number 15/NW/0685.

: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).